These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 1673627)

  • 21. C-ERBB-2 gene amplification as a prognostic marker in human bladder cancer.
    Miyamoto H; Kubota Y; Noguchi S; Takase K; Matsuzaki J; Moriyama M; Takebayashi S; Kitamura H; Hosaka M
    Urology; 2000 May; 55(5):679-83. PubMed ID: 10792078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
    Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
    J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between the expression of oncogenes ras and c-erbB-2 and the biological behavior of bladder tumors.
    Ye DW; Zheng JF; Qian SX; Ma YJ
    Urol Res; 1993 Jan; 21(1):39-43. PubMed ID: 8096102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique.
    Orlando C; Sestini R; Vona G; Pinzani P; Bianchi S; Giacca M; Pazzagli M; Selli C
    J Urol; 1996 Dec; 156(6):2089-93. PubMed ID: 8911396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KIAA1096, a gene on chromosome 1q, is amplified and overexpressed in bladder cancer.
    Huang WC; Taylor S; Nguyen TB; Tomaszewski JE; Libertino JA; Malkowicz SB; McGarvey TW
    DNA Cell Biol; 2002 Oct; 21(10):707-15. PubMed ID: 12443540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas.
    Walker RA; Senior PV; Jones JL; Critchley DR; Varley JM
    J Pathol; 1989 Jun; 158(2):97-105. PubMed ID: 2569035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-erbB-2 gene amplification: a molecular marker in recurrent bladder tumors?
    Underwood M; Bartlett J; Reeves J; Gardiner DS; Scott R; Cooke T
    Cancer Res; 1995 Jun; 55(11):2422-30. PubMed ID: 7757996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amplification and overexpression of the c-erbB-2 protooncogene in human gastric cancer.
    Sasaki K; Tomita Y; Azuma M; Shida S; Simizu B
    Gastroenterol Jpn; 1992 Apr; 27(2):172-8. PubMed ID: 1577221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interrelationship between expression of p53, proliferating cell nuclear antigen and c-erbB-2 in bladder cancer.
    Lipponen PK
    Pathobiology; 1993; 61(3-4):178-82. PubMed ID: 8105802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. c-jun oncogene expression in transitional cell carcinoma of the urinary bladder.
    Tiniakos DG; Mellon K; Anderson JJ; Robinson MC; Neal DE; Horne CH
    Br J Urol; 1994 Dec; 74(6):757-61. PubMed ID: 7827848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 and erbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancer.
    Moch H; Sauter G; Moore D; Mihatsch MJ; Gudat F; Waldman F
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):329-34. PubMed ID: 7509541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer.
    Ow K; Delprado W; Fisher R; Barrett J; Yu Y; Jackson P; Russell PJ
    J Pathol; 2000 May; 191(1):39-47. PubMed ID: 10767717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amplification of the c-erbB-2 gene in gastric carcinoma: correlation with survival.
    Tsugawa K; Fushida S; Yonemura Y
    Oncology; 1993; 50(6):418-25. PubMed ID: 7901825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
    Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma.
    Sato K; Moriyama M; Mori S; Saito M; Watanuki T; Terada K; Okuhara E; Akiyama T; Toyoshima K; Yamamoto T
    Cancer; 1992 Nov; 70(10):2493-8. PubMed ID: 1358427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniques.
    Nedjadi T; Al-Maghrabi J; Assidi M; Dallol A; Al-Kattabi H; Chaudhary A; Al-Sayyad A; Al-Ammari A; Abuzenadah A; Buhmeida A; Al-Qahtani M
    BMC Cancer; 2016 Aug; 16():653. PubMed ID: 27539085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of immunohistochemically demonstrated c-erb B-2 oncoprotein expression as a prognostic factor in transitional cell carcinoma of the urinary bladder.
    Lipponen P; Eskelinen M; Syrjänen S; Tervahauta A; Syrjänen K
    Eur Urol; 1991; 20(3):238-42. PubMed ID: 1688050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.
    Bringuier PP; Tamimi Y; Schuuring E; Schalken J
    Oncogene; 1996 Apr; 12(8):1747-53. PubMed ID: 8622895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlations between c-erb beta-2 oncogene amplification and the expression of its mRNA and protein in human breast carcinomas.
    Bandyopadhyay D; Dani HD; Samant UC; Redkar AA; Mittra I
    Oncology; 1992; 49(1):9-14. PubMed ID: 1347417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.